Pentapeptide sharing between Corynebacterium diphtheria toxin and the human neural protein network

Immunopharmacology and Immunotoxicology

Volumn 33, Issue 2, 2011, Pages 360-372

  Bavaro, Simona Lucia ^a   Calabrò, Michele ^a   Kanduc, Darja ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Comparative peptidomics; corynebacterium diphtheria; cross reactivity; diphtheria toxin; neural protein network; peptide sharing

Indexed keywords

BARDET BIEDL SYNDROME 9 PROTEIN; CONTACTIN; CONTACTIN 4; DIPHTHERIA TOXIN; MERLIN; NEUROLIGIN; NUCLEAR PROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; PENTAPEPTIDE; PERIAXIN; REELIN; SEMAPHORIN; SEMAPHORIN 5A; SODIUM CHANNEL; SODIUM CHANNEL PROTEIN TYPE 1 SUBUNIT A; TUBERIN; TUBEROUS SCLEROSIS PROTEIN 1; UNCLASSIFIED DRUG; WILLIAMS BEUREN SYNDROME CHROMOSOMAL REGION 1 PROTEIN; WILLIAMS BEUREN SYNDROME CHROMOSOMAL REGION 8 PROTEIN;

ARTICLE; AUTISM; NERVE CELL NETWORK; PEPTIDOMICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AMINO ACID SEQUENCE; DIPHTHERIA TOXIN; HUMANS; MOLECULAR SEQUENCE DATA; NERVE NET; NERVE TISSUE PROTEINS; OLIGOPEPTIDES; SEQUENCE HOMOLOGY, AMINO ACID;

BACTERIA (MICROORGANISMS); CORYNEBACTERIUM DIPHTHERIAE;

EID: 79955855050     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2010.518618     Document Type: Article

References (130)

1. Guttmacher AE, Collins FS. Welcome to the genomic era. N Engl J Med 2003;349:996-998. (Pubitemid 37064775)
2. McClellan J, King MC. Genetic heterogeneity in human disease. Cell 2010;141:210-217.
3. Kanduc D. Protein information content resides in rare peptide segments. Peptides 2010;31:983-988.
4. Menschaert G, Vandekerckhove TT, Baggerman G, Schoofs L, Luyten W, Van Criekinge W. Peptidomics coming of age: a review of contributions from a bioinformatics angle. J Proteome Res 2010;9:2051-2061.
5. Lucchese G, Stufano A, Trost B, Kusalik A, Kanduc D. Peptidology: short amino acid modules in cell biology and immunology. Amino Acids 2007;33:703-707. (Pubitemid 350165425)
6. Kanduc D, Stufano A, Lucchese G, Kusalik A. Massive peptide sharing between viral and human proteomes. Peptides 2008;29:1755-1766.
7. Trost B, Kusalik A, Lucchese G, Kanduc D. Bacterial peptides are intensively present throughout the human proteome. Self/Nonself 2010;1:71-74.
8. Wu CH, Yeh LS, Huang H, Arminski L, Castro-Alvear J, Chen Y, et al. Te protein information resource. Nucleic Acids Res 2003;31:345-347.
9. Veenstra-VanderWeele J, Kim SJ, Lord C, Courchesne R, Akshoomof N, Leventhal BL, et al. Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet 2002;114:277-283. (Pubitemid 34258851)
10. Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S, et al. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 2006;163:934-936. (Pubitemid 44464547)
11. Splawski I, Timothy KW, Sharpe LM, Decher N Kumar P, Bloise R, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004;119:19-31. (Pubitemid 39349317)
12. Smalley SL. Autism and tuberous sclerosis. J Autism Dev Disord 1998;28:407-414. (Pubitemid 29101856)
13. Choi YJ, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev 2008;22:2485-2495.
14. Bolton PF. Neuroepileptic correlates of autistic symptomatology in tuberous sclerosis. Ment Retard Dev Disabil Res Rev 2004;10:126-131. (Pubitemid 39329019)
15. Persico AM, DAgruma L, Maiorano N Totaro A, Militerni R, Bravaccio C, et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 2001;6: 150-159. (Pubitemid 32187864)
16. Serajee FJ, Zhong H, Mahbubul Huq AH. Association of Reelin gene polymorphisms with autism. Genomics 2006;87:75-83. (Pubitemid 43005104)
17. Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, et al. Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry 2005;10:563-571. (Pubitemid 40897040)
18. Li H, Li Y Shao J, Li R, Qin Y, Xie C, et al. Te association analysis of RELN and GRM8 genes with autistic spectrum disorder in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2008;147B:194-200. (Pubitemid 351355280)
19. Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N et al. Lack of evidence for an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet B Neuropsychiatr Genet 2004;126B:51-57. (Pubitemid 38420121)
20. Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, et al. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Med Genet B Neuropsychiatr Genet 2004;126B:46-50. (Pubitemid 38420120)
21. Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, et al. Analysis of reelin as a candidate gene for autism. Mol Psychiatry 2003;8:885-892. (Pubitemid 37346543)
22. Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M, et al. Absence of association between a polymorphic GGC repeat in the 5' untranslated region of the reelin gene and autism. Mol Psychiatry 2002;7:801-804. (Pubitemid 34984960)
23. Nakamine A, Ouchanov L, Jiménez P, Manghi ER, Esquivel M, Monge S, et al. Duplication of 17(p11.2p11.2) in a male child with autism and severe language delay. Am J Med Genet A 2008;146A:636-643.
24. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 2003;33:466-468. (Pubitemid 36390007)
25. Zhang F, Potocki L, Sampson JB, Liu P, Sanchez-Valle A, Robbins-Furman P, et al. Identifcation of uncommon recurrent Potocki-Lupski syndrome-associated duplications and the distribution of rearrangement types and mechanisms in PTLS. Am J Hum Genet 2010;86:462-470.
26. van der Zwaag B, Franke L, Poot M, Hochstenbach R, Spierenburg HA, Vorstman JA, et al. Gene-network analysis identifes susceptibility genes related to glycobiology in autism. PLoS One 2009;4:e5324.
27. Williams SR, Girirajan S, Tegay D, Nowak NJ, Hatchwell E, Elsea SH. Array comparative genomic hybridization of 52 subjects with a Smith-Magenis-like phenotype: identifcation of dosage-sensitive loci also associated with schizophrenia, autism, and developmental delay. J Med Genet 2010;47:223-229.
28. Philippi A, Tores F, Carayol J, Rousseau F, Letexier M, Roschmann E, et al. Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis. BMC Med Genet 2007;8:74.
29. Serajee FJ, Nabi R, Zhong H, Mahbubul Huq AH. Association of INPP1, PIK3CG, and TSC2 gene variants with autistic disorder: implications for phosphatidylinositol signalling in autism. J Med Genet 2003;40:e119.
30. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009;5:e1000536.
31. Castermans D, Wilquet V Parthoens E, Huysmans C, Steyaert J, Swinnen L, et al. Te neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet 2003;40:352-356. (Pubitemid 36613473)
32. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. Te neurobeachin gene spans the common fragile site FRA13A. Hum Genet 2006;118:551-558. (Pubitemid 41825127)
33. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009;459:569-573.
34. James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006;141B:947-956. (Pubitemid 44905454)
35. Nelson PG, Kuddo T, Song EY, Dambrosia JM, Kohler S, Satyanarayana G, et al. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int J Dev Neurosci 2006;24:73-80. (Pubitemid 43287950)
36. Marui T, Hashimoto O, Nanba E, Kato C, Tochigi M, Umekage T, et al. Association between the neurofbromatosis-1 (NF1) locus and autism in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2004;131B:43-47. (Pubitemid 39458436)
37. Plank SM, Copeland-Yates SA, Sossey-Alaoui K, Bell JM, Schroer RJ, Skinner C, et al. Lack of association of the (AAAT)6 allele of the GXAlu tetranucleotide repeat in intron 27b of the NF1 gene with autism. Am J Med Genet 2001;105:404-405. (Pubitemid 32601589)
38. Mbarek O, Marouillat S, Martineau J, Barthélémy C, Müh JP, Andres C. Association study of the NF1 gene and autistic disorder. Am J Med Genet 1999;88:729-732.
39. Roohi J, Montagna C, Tegay DH, Palmer LE, DeVincent C, Pomeroy JC, et al. Disruption of contactin 4 in three subjects with autism spectrum disorder. J Med Genet 2009;46:176-182.
40. Beyer KS, Klauck SM, Benner A, Poustka F, Poustka A. Association studies of the HOPA dodecamer duplication variant in diferent subtypes of autism. Am J Med Genet 2002;114:110-115.
41. Michaelis RC, Copeland-Yates SA, Sossey-Alaoui K, Skinner C, Friez MJ, Longshore JW, et al. Te HOPA gene dodecamer duplication is not a signifcant etiological factor in autism. J Autism Dev Disord 2000;30:355-358.
42. Philibert RA. A meta-analysis of the association of the HOPA12bp polymorphism and schizophrenia. Psychiatr Genet 2006;16:73-76. (Pubitemid 44481208)
43. Henningsson S, Jonsson L, Ljunggren E, Westberg L, Gillberg C, Råstam M, et al. Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology 2009;34:752-761.
44. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex diferences in the brain: implications for explaining autism. Science 2005;310:819-823. (Pubitemid 41567334)
45. Melin M, Carlsson B, Anckarsater H, Rastam M, Betancur C, Isaksson A, et al. Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology 2006;54:64-69. (Pubitemid 44699463)
46. Klauck SM, Felder B, Kolb-Kokocinski A, Schuster C, Chiocchetti A, Schupp I, et al. Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol Psychiatry 2006;11:1073-1084. (Pubitemid 44863432)
47. Zhou XL, Giacobini M, Anderlid BM, Anckarsäter H, Omrani D, Gillberg C, et al. Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD). Am J Med Genet B Neuropsychiatr Genet 2007;144B:351-354. (Pubitemid 46642027)
48. Nurmi EL, Amin T, Olson LM, Jacobs MM, McCauley JL, Lam AY, et al. Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autism. Mol Psychiatry 2003;8:624-634. (Pubitemid 36898021)
49. Kim SJ, Herzing LB, Veenstra-VanderWeele J, Lord C, Courchesne R, Leventhal BL, et al. Mutation screening and transmission disequilibrium study of ATP10C in autism. Am J Med Genet 2002;114:137-143. (Pubitemid 34160463)
50. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C, et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009;2:157-177.
51. Castermans D, Vermeesch JR, Fryns JP, Steyaert JG, Van de Ven WJ, Creemers JW, et al. Identifcation and characterization of the TRIP8 and REEP3 genes on chromosome 10q21.3 as novel candidate genes for autism. Eur J Hum Genet 2007;15:422-431. (Pubitemid 46487697)
52. Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, et al. Sodium channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry 2003;8:186-194. (Pubitemid 36315227)
53. Wolf M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological fndings. Epilepsia 2006;47(S2):45-48. (Pubitemid 44684620)
54. Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N Montal M, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 2004;24:2690-2698. (Pubitemid 38380945)
55. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol 2005;20:790-795. (Pubitemid 43124466)
56. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009;459:528-533.
57. Hinton VJ, Cyrulnik SE, Fee RJ, Batchelder A, Kiefel JM, Goldstein EM, et al. Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol 2009;41:339-346.
58. Young HK, Barton BA, Waisbren S, Portales Dale L, Ryan MM, Webster RI, et al. Cognitive and psychological profle of males with Becker muscular dystrophy. J Child Neurol 2008;23: 155-162.
59. Hendriksen JG, Vles JS. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-defcit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008;23:477-481. (Pubitemid 351566858)
60. Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E. Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol Appl Neurobiol 2004;30:615-623. (Pubitemid 39564181)
61. Laumonnier F, Roger S, Guérin P, Molinari F, M'rad R, Cahard D, et al. Association of a functional defcit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am J Psychiatry 2006;163:1622-1629. (Pubitemid 44465764)
62. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science 2007;316:445-449. (Pubitemid 46651493)
63. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci USA 2005;102:8089-8096. (Pubitemid 40800048)
64. Barrett CF, Tsien RW. Te Timothy syndrome mutation diferentially afects voltage-and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc Natl Acad Sci USA 2008;105:2157-2162. (Pubitemid 351439481)
65. Sikora DM, Pettit-Kekel K, Penfeld J, Merkens LS, Steiner RD. Te near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A 2006;140:1511-1518. (Pubitemid 43993109)
66. Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, et al. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci USA 1998;95:8181-8186.
67. Bacchelli E, Blasi F, Biondolillo M, Lamb JA, Bonora E, Barnby G, et al. Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 2003;8:916-924. (Pubitemid 37421698)
68. Argüelles P, Arias A, Vilaseca MA, Ribes A, Artuch R, Sans-Fito A, et al. X-Linked creatine transporter defciency in two patients with severe mental retardation and autism. J Inherit Metab Dis 2006;29:220-223.
69. Zhao C, Xu Z, Chen J, Yu Z, Tong KL, Lo WS, et al. Two isoforms of GABA(A) receptor beta2 subunit with diferent electrophysiological properties: diferential expression and genotypical correlations in schizophrenia. Mol Psychiatry 2006;11:1092-1105. (Pubitemid 44863434)
70. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsäter H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008;13:90-98. (Pubitemid 350275181)
71. Jamain S, Quach H, Betancur C, Råstam M, Colineaux C, Gillberg IC, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27-29. (Pubitemid 36548785)
72. Ylisaukko-oja T, Rehnström K, Auranen M, Vanhala R, Alen R, Kempas E, et al. Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet 2005;13:1285-1292. (Pubitemid 43090531)
73. Wermter AK, Kamp-Becker I, Strauch K, Schulte-Körne G, Remschmidt H. No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level. Am J Med Genet B Neuropsychiatr Genet 2008;147B: 535-537. (Pubitemid 351830818)
74. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007;318:71-76. (Pubitemid 47538032)
75. De Jaco A, Comoletti D, Kovarik Z, Gaietta G, Radic Z, Lockridge O, et al. A mutation linked with autism reveals a common mechanism of endoplasmic reticulum retention for the alpha,beta-hydrolase fold protein family. J Biol Chem 2006;281:9667-9676. (Pubitemid 43864685)
76. Zhang C, Milunsky JM, Newton S, Ko J, Zhao G, Maher TA, et al. A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export. J Neurosci 2009;29:10843-10854.
77. Talebizadeh Z, Lam DY, Teodoro MF, Bittel DC, Lushington GH, Butler MG. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 2006;43:e21.
78. Pampanos A, Volaki K, Kanavakis E, Papandreou O, Youroukos S, Tomaidis L, et al. A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. Genet Test Mol Biomarkers 2009;13:611-615.
79. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J. Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 2008;16:614-618. (Pubitemid 351594128)
80. Graf ER, Kang Y, Hauner AM, Craig AM. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 2006;26:4256-4265. (Pubitemid 44315385)
81. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, et al. Te male-specifc region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003;423:825-837. (Pubitemid 36781267)
82. Orabona GM, Griesi-Oliveira K, Vadasz E, Bulcão VL, Takahashi VN, Moreira ES, et al. HTR1B and HTR2C in autism spectrum disorders in Brazilian families. Brain Res 2009;1250:14-19.
83. Wu S, Jia M, Ruan Y, Liu J, Guo Y, Shuang M, et al. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 2005;58:74-77. (Pubitemid 40909939)
84. Wermter AK, Kamp-Becker I, Hesse P, Schulte-Körne G, Strauch K, Remschmidt H. Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Am J Med Genet B Neuropsychiatr Genet 2010;153B:629-639.
85. Yrigollen CM, Han SS, Kochetkova A, Babitz T, Chang JT, Volkmar FR, et al. Genes controlling afliative behavior as candidate genes for autism. Biol Psychiatry 2008;63:911-916.
86. Jacob S, Brune CW, Carter CS, Leventhal BL, Lord C, Cook EH Jr. Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism. Neurosci Lett 2007;417:6-9. (Pubitemid 46517832)
87. Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition. Mol Psychiatry 2008;13:980-988.
88. Gregory SG, Connelly JJ, Towers AJ, Johnson J, Biscocho D, Markunas CA, et al. Genomic and epigenetic evidence for oxytocin receptor defciency in autism. BMC Med 2009;7:62.
89. Rojas Walh RU. G-protein coupled receptors & autism refections on a double-edged sword at the example of the oxytocin receptor system. Indian J Med Res 2007;126:13-21.
90. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 2009;66:947-956.
91. Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol 2010;23:189-193.
92. D'Hulst C, Kooy RF. Fragile X syndrome: from molecular genetics to therapy. J Med Genet 2009;46:577-584.
93. Gambardella A, Marini C. Clinical spectrum of SCN1A mutations. Epilepsia 2009;50(S5):20-23.
94. Shimizu H, Iwayama Y, Yamada K, Toyota T, Minabe Y Nakamura K, et al. Genetic and expression analyses of the STOP (MAP6) gene in schizophrenia. Schizophr Res 2006;84: 244-252.
95. Francks C, Maegawa S, Laurén J, Abrahams BS, Velayos-Baeza A, Medland SE, et al. LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry 2007;12:1129-1139. (Pubitemid 350191361)
96. Osborne LR, Martindale DW, Scherer SW, Shi X-M, Huizenga J, Heng HHQ, et al. Identifcation of genes from a 500-kb region at 7q11.23 that is commonly deleted in Williams syndrome patients. Genomics 1996;36:328-336. (Pubitemid 26307496)
97. Wilson MD, Wang D, Burke RD, Chen X, Duronio V, Koop BF. Comparative genomic sequence analysis of the Williams syndrome region (LIMK1-RFC2) of human chromosome 7q11.23. Mamm Genome 2000;11:890-898.
98. Dose AC, Burnside B. A class III myosin expressed in the retina is a potential candidate for Bardet-Biedl syndrome. Genomics 2002;79:621-624. (Pubitemid 34499476)
99. Zaghloul NA, Liu Y, Gerdes JM, Gascue C, Oh EC, Leitch CC, et al. Functional analyses of variants reveal a signifcant role for dominant negative and common alleles in oligogenic Bardet-Biedl syndrome. Proc Natl Acad Sci USA 2010;107:10602-10607.
100. Marion V, Stoetzel C, Schlicht D, Messaddeq N, Koch M, Flori E, et al. Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic diferentiation. Proc Natl Acad Sci USA 2009;106:1820-1825.
101. Seo S, Baye LM, Schulz NP, Beck JS, Zhang Q, Slusarski DC, et al. BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc Natl Acad Sci USA 2010;107:1488-1493.
102. Stoetzel C, Laurier V, Davis EE, Muller J, Rix S, Badano JL, et al. BBS10 encodes a vertebrate-specifc chaperonin-like protein and is a major BBS locus. Nat Genet 2006;38:521-524.
103. Doll A, Grzeschik K-H. Characterization of two novel genes, WBSCR20 and WBSCR22, deleted in Williams-Beuren syndrome. Cytogenet Cell Genet 2001;95:20-27. (Pubitemid 34461821)
104. Gorman SW, Haider NB, Grieshammer U, Swiderski RE, Kim E, Welch JW, et al. Te cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22-q23. Genomics 1999;59:150-160. (Pubitemid 29365345)
105. Fan Y Esmail MA, Ansley SJ, Blacque OE, Boroevich K, Ross AJ, et al. Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet 2004;36:989-993. (Pubitemid 39167496)
106. Te international Joubert syndrome related disorders (JSRD) study group, Cantagrel V, Silhavy JL, Bielas SL, Swistun D, Marsh SE, Bertrand JY, et al. Mutations in the cilia gene ARL13B lead to the classical form of Joubert syndrome. Am J Hum Genet 2008; 83: 170-179.
107. Merla G, Ucla C, Guipponi M, Reymond A. Identifcation of additional transcripts in the Williams-Beuren syndrome critical region. Hum Genet 2002;110:429-438. (Pubitemid 36074988)
108. Paperna T, Peoples R, Wang YK, Kaplan P, Francke U. Genes for the CPE receptor (CPETR1) and the human homolog of RVP1 (CPETR2) are localized within the Williams-Beuren syndrome deletion. Genomics 1998;54:453-459. (Pubitemid 29036232)
109. May-Simera HL, Ross A, Rix S, Forge A, Beales PL, Jagger DJ. Patterns of expression of Bardet-Biedl syndrome proteins in the mammalian cochlea suggest noncentrosomal functions. J Comp Neurol 2009;514:174-188.
110. Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC, et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003;425:628-633. (Pubitemid 37280147)
111. Kim JC, Badano JL, Sibold S, Esmail MA, Hill J, Hoskins BE, et al. Te Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat Genet 2004;36:462-470. (Pubitemid 38620029)
112. Nishimura DY, Swiderski RE, Searby CC, Berg EM, Ferguson AL, Hennekam R, et al. Comparative genomics and gene expression analysis identifes BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet 2005;77:1021-1033. (Pubitemid 41698522)
113. Maystadt I, Rezsoehazy R, Barkats M, Duque S, Vannufel P, Remacle S, et al. Te nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet 2007;81:67-76. (Pubitemid 47001157)
114. Barlow GM, Micales B, Chen X-N, Lyons GE, Korenberg JR. Mammalian DSCAMs: roles in the development of the spinal cord, cortex, and cerebellum? Biochem Biophys Res Commun 2002;293:881-891. (Pubitemid 34694124)
115. Armstrong RC, Kim JG, Hudson LD. Expression of myelin transcription factor I (MyTI), a 'zinc-fnger' DNA-binding protein, in developing oligodendrocytes. Glia 1995;14:303-321.
116. Nielsen JA, Berndt JA, Hudson LD, Armstrong RC. Myelin transcription factor 1 (Myt1) modulates the proliferation and diferentiation of oligodendrocyte lineage cells. Mol Cell Neurosci 2004;25:111-123. (Pubitemid 38228347)
117. Aston C, Jiang L, Sokolov BP. Transcriptional profling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005;10:309-322. (Pubitemid 40432684)
118. Angelo PF, Lima AR, Alves FM, Blaber SI, Scarisbrick IA, Blaber M, et al. Substrate specifcity of human kallikrein 6: salt and glycosaminoglycan activation efects. J Biol Chem 2006;281:3116-3126. (Pubitemid 43845921)
119. Kanduc D. "Self-nonself peptides in the design of vaccines. Curr Pharm Des 2009;15:3283-3289.
120. Rothbard JB, Gefter ML. Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 1991;9: 527-565.
121. Tiwari R, Geliebter J, Lucchese A, Mittelman A, Kanduc D. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity. Peptides 2004;25:1865-1871. (Pubitemid 39389180)
122. Reddehase MJ, Rothbard JB, Koszinowski UH. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 1989;337:651-653. (Pubitemid 19054293)
123. Yang D, Oyaizu Y, Oyaizu H, Olsen GJ, Woese CR. Mitochondrial origins. Proc Natl Acad Sci USA 1985;82:4443-4447. (Pubitemid 15234250)
124. Mattos-Guaraldi AL, Duarte Formiga LC, Pereira GA. Cell surface components and adhesion in Corynebacterium diphtheria. Microbes Infect 2000;2:1507-1512.
125. Vimr E, Lichtensteiger C. To sialylate, or not to sialylate: that is the question. Trends Microbiol 2002;10:254-257. (Pubitemid 34671142)
126. Cryz SJ, Welkos SL, Holmes RK. Immunochemical studies of diphtherial toxin and related nontoxic mutant proteins. Infect Immun 1980;30:835-846. (Pubitemid 11199583)
127. Neal SE, Efstratiou A; DIPNET; International Diphtheria Reference Laboratories. International external quality assurance for laboratory diagnosis of diphtheria. J Clin Microbiol 2009;47:4037-4042.
128. Martín-Muñoz MF, Pereira MJ, Posadas S, Sánchez- Sabaté E, Blanca M, Alvarez J. Anaphylactic reaction to diphtheria-tetanus vaccine in a child: specifc IgE/IgG determinations and cross-reactivity studies. Vaccine 2002;20:3409-3412. (Pubitemid 35245824)
129. Kubota M, Takahashi Y. Steroid-responsive chronic cerebellitis with positive glutamate receptor delta 2 antibody. J Child Neurol 2008;23:228-230.
130. Huynh W, Cordato DJ, Kehdi E, Masters LT, Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci 2008;15:1315-1322.